TY  - JOUR
AU  - Ávalos-Moreno, Marta
AU  - López-Tejada, Araceli
AU  - Blaya-Cánovas, Jose L
AU  - Cara-Lupiañez, Francisca E
AU  - González-González, Adrián
AU  - Lorente, Jose A
AU  - Sánchez-Rovira, Pedro
AU  - Granados-Principal, Sergio
PY  - 2020
DO  - 10.3390/jpm10040200
SN  - 2075-4426
UR  - https://hdl.handle.net/10668/24547
T2  - Journal of personalized medicine
AB  - Triple-negative breast cancer (TNBC) is the most aggressive type of breast cancer which presents a high rate of relapse, metastasis, and mortality. Nowadays, the absence of approved specific targeted therapies to eradicate TNBC remains one of the main...
LA  - en
KW  - cancer stem cells
KW  - clinical trials
KW  - computational methods
KW  - drug repurposing
KW  - personalized medicine
KW  - triple-negative breast cancer
TI  - Drug Repurposing for Triple-Negative Breast Cancer.
TY  - research article
VL  - 10
ER  -